ArticleNature and science of sleep2025
Association Between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease: Epidemiological Cross-Sectional Study and Mendelian Randomization Analysis.
Article in Nature and science of sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Metabolic Dysfunction-Associated Steatotic Liver Disease and Respiratory Disorders: A Systematic Review of Clinical and Pathophysiological Associations.Current obesity reports · 2026Pooled it
- Obstructive sleep apnea mediates the association between body mass index and metabolic dysfunction-associated steatotic liver disease in patients with obesity.Hepatology international · 2026Article
- Metabolic dysfunction-associated steatotic liver disease and obstructive sleep apnea: A cohort analysis of prevalence and hepatic outcomes.World journal of gastrointestinal pharmacology and therapeutics · 2026Article
- The Relationship Between Chronic Intermittent Hypoxia and MASLD and Fibrosis in Obstructive Sleep Apnea Patients.Journal of clinical medicine · 2026Article
- Assessing metabolic-dysfunction associated steatotic liver disease in patients with obstructive sleep apnea: a cross-sectional study.Sleep & breathing = Schlaf & Atmung · 2026Article
- The Beauty Sleep to Keep a Healthy Liver.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Obstructive sleep apnea (OSA) is a common condition that is linked to various complications. Despite its prevalence, limited research has explored the association between OSA and non-alcoholic fatty liver disease (NAFLD). The aim of this study was to examine whether individuals at risk for OSA are more likely to develop NAFLD. Patients and Methods: This study employed a cross-sectional design coupled with Mendelian randomization, using data from the National Health and Nutrition Examination Survey (NHANES) collected between 2017 and 2020. A total of 6215 eligible participants were included. Multivariable logistic regression was performed to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for the relationship between OSA and NAFLD, adjusting for age, sex, ethnicity, education level, body mass index (BMI), diabetes, and hypertension. To assess causal inference and minimize observational bias, five distinct two-sample Mendelian randomization approaches were applied. Results: After excluding 9345 individuals who did not meet the study criteria, a total of 6215 participants were included. The weighted prevalence of OSA and NAFLD in the cohort was 43.1% and 43.0%, respectively. Compared with individuals without NAFLD, those with NAFLD were older (median age 52.0 vs 44.0 years), and exhibited higher levels of HbA1c (5.70% vs 5.40%), fasting glucose, total cholesterol, triglycerides, and liver enzymes such as ALT. Additionally, NAFLD patients had markedly higher rates of comorbid conditions including hypertension (65% vs 40%), diabetes (29% vs 14%), and OSA (51% vs 36%). After adjusting for potential confounders, multivariable logistic regression demonstrated a significant association between OSA and NAFLD (OR = 1.86, 95% CI: 1.63-2.11, p < 0.001). Mendelian randomization analysis further suggested a potential causal effect of genetically predicted OSA on NAFLD risk (IVW OR = 1.066, 95% CI: 1.010-1.125, p = 0.020). Conclusion: These findings suggest a potential association between OSA and the development of NAFLD. While the results provide preliminary evidence for a link, further longitudinal and interventional studies are needed to clarify causality and inform clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.